WILHOIT SCOTT L. (Chief Commercial Officer) reported 1 transaction at STRONGBRIDGE BIOPHARMA PLC
Review the transaction codes below to understand the nature of each event.
Filed: 10/6/2021ACC: 0001179110-21-009285
Officer· Chief Commercial Officer
Since May 2019
-758.51K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
758.51K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−109.51K
Price / share
—
Trade value
—
% of position
New position
10/5/2021
109.51K→0.00
Total
Net shares
−109.51K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 10/5/2021 | D · Disposition | −109.51K | — | — | New position | 109.51K | 0.00 |
| Total | −109.51K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
649K shares
Shares
−649K
Strike price
Held after
0.00
Exercisable
—
10/5/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Ordinary Shares649K shares | 10/5/2021 | D · Disposition | −649K | — | 0.00 |